After introducing next-generation sequencing technology, it is now possible to sequence foetal DNA fragments that can be built into a whole genetic map, allowing the foetal genome to be inspected prenatally and non-invasively. Novel screening approaches for foetal chromosomal aneuploidies have been developed as a result of advances in molecular technologies and the identification of cell-free foetal DNA in maternal plasma.
Frequently Asked Questions
The market is segmented based on Global Non-invasive Prenatal Testing Market Segmentation, By Product and Services (Products, Services), Method (Ultrasound Detection, Biochemical Screening Test, Cell-Free DNA in Maternal Plasma Tests), Application (Trisomy, Microdeletion Syndrome, Other), End-User (Diagnostic Laboratories, Hospitals), Test Type (Materni21, Harmony, Panorama, Verify, NIFTY, Others), Technology (NGS, WGS, Others) – Industry Trends and Forecast to 2032
.
The Global Non Invasive Prenatal Testing Market size was valued at USD 4.75 USD Billion in 2024.
The Global Non Invasive Prenatal Testing Market is projected to grow at a CAGR of 13.8% during the forecast period of 2025 to 2032.
The market report covers data from the .
